The United Kingdom government on Tuesday approved dexamethasone for treating novel coronavirus (COVID-19) patients, the country’s Health Ministry said.
“Thousands of lives will be saved in the UK with the government immediately authorising the NHS (the National Health Service) to use the world’s first coronavirus treatment proven to reduce the risk of death,” the Health Ministry said in a statement.
In United Kingdom recovery trials, Dexamethasone, an anti-inflammatory drug, has emerged as new hope in fight against Covid-19. It is the first drug that has proven to reduce deaths in Covid-19 patients.
Dexamethasone drugs should only be used on patients who are already dependent on oxygen supply and on ventilator. The drug reduced the 28-Day mortality rate by 17 percent, and proven to reduce the risk of death in Covid-19 patients on ventilation by 35 percent and patients on Oxygen by 20 percent.
The UK Prime Minister Boris Johnson hailed the successful trial during his press conference.
“Today, there is genuine cause to celebrate a remarkable British scientific achievement, and the benefits it will bring, not just in this country but around the world,” the Guardian quoted him as saying.
“This drug, dexamethasone, can now be made available across the NHS, and we’ve taken steps to ensure we have enough supplies, even in the event of a second peak,” he added.
The World Health Organisation (WHO) also welcomed the preliminary results about dexamethasone use in treating critically ill COVID-19 patients.
“This is the first treatment to be shown to reduce mortality in patients with COVID-19 requiring oxygen or ventilator support,” Dr Tedros Adhanom Ghebreyesus, WHO Director-General, said in a statement.
“This is great news and I congratulate the Government of the UK, the University of Oxford, and the many hospitals and patients in the UK who have contributed to this lifesaving scientific breakthrough,” Ghebreyesus added.
With Inputs from UNI